Skip to main content
Livermore
Livermore
ZHEN

Ayrton Capital LLC

SEC CIK
0001698148
Latest filing
Nov 13, 2023

The latest 13F from Ayrton Capital LLC covers Q3 2023 (filed Nov 13, 2023): 71 long positions worth $14.7M. The top 10 holdings make up 88.0% of the portfolio, and the largest is Mannkind Corp at 34.2%. Livermore has 8 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q3 2023

Share counts compared with Q2 2023: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$863.0K
Added
3
Est. +$655.7K
Reduced
2
Est. −$406.9K
Sold out
10
Est. −$1.66M

Top 5 holdings

Share of this quarter's portfolio value

  1. Mannkind Corp56400PAQ5
    34.2%$5.02M
  2. RingCentral, Inc.76680RAF4
    12.6%$1.85M
  3. Nogin, Inc.65528NAB1
    8.2%$1.21M
  4. SHFSSHF Holdings, Inc.
    6.3%$930.8KHistory
  5. Cloudflare, Inc.18915MAC1
    5.8%$851.9K

Biggest buys

New and added positions, by estimated amount bought

  1. PAVMPAVmed Inc.
    +$528.7KAddedHistory
  2. CREXCreative Realities, Inc.
    +$397.7KNewHistory
  3. TBLTToughbuilt Industries, Inc
    +$219.1KNewHistory
  4. ATXGAddentax Group Corp.
    +$116.9KAddedHistory
  5. LUCDLucid Diagnostics Inc.
    +$86.5KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. PAVMPAVmed Inc.
    +3.36 pp1.1% → 4.5%History
  2. CREXCreative Realities, Inc.
    +2.71 pp0.0% → 2.7%History
  3. TBLTToughbuilt Industries, Inc
    +1.49 pp0.0% → 1.5%History
  4. LUCDLucid Diagnostics Inc.
    +0.59 pp0.0% → 0.6%History
  5. Tritium DCFCQ9225T108
    +0.56 pp0.0% → 0.6%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. GSR II Meteora Acquisitn Cor36263W105
    −$1.05MSold out
  2. PMCBPharmaCyte Biotech, Inc.
    −$388.3KReducedHistory
  3. EUDAEUDA Health Holdings Ltd
    −$359.4KSold outHistory
  4. 1847 Goedeker Inc28252C117
    −$129.8KSold out
  5. KSCPKnightscope, Inc.
    −$67.9KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GSR II Meteora Acquisitn Cor36263W105
    −6.54 pp6.5% → 0.0%
  2. PMCBPharmaCyte Biotech, Inc.
    −3.63 pp4.9% → 1.3%History
  3. EUDAEUDA Health Holdings Ltd
    −2.24 pp2.2% → 0.0%History
  4. SHPHShuttle Pharmaceuticals Holdings, Inc.
    −0.89 pp1.8% → 0.9%History
  5. 1847 Goedeker Inc28252C117
    −0.81 pp0.8% → 0.0%

Metrics

13F metrics for Q3 2023, computed only from the numbers in the filings. Definitions below.

Portfolio value
$14.7M
−$1.33M (−8.3%) vs. prior quarter
Positions
71
−3 vs. prior quarter
Top 10 concentration
88.0%
Top 10 as share of value
Turnover
9.9%
Q3 2023, one quarter
Average holding period
5.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

8 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $106.1M (Q4 2021)

Q4 2021: $106.1MQ1 2022: $76.9MQ2 2022: $61.6MQ3 2022: $57.0MQ4 2022: $36.5MQ1 2023: $27.9MQ2 2023: $16.0MQ3 2023: $14.7M
Q4 2021Q3 2023
13F filings of Ayrton Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2023Nov 13, 202371$14.7MMannkind CorpRingCentral, Inc.Nogin, Inc.vs. Q2 2023SEC
Q2 2023Aug 14, 202374$16.0MMannkind CorpRingCentral, Inc.Nogin, Inc.vs. Q1 2023SEC
Q1 2023May 12, 202385$27.9MMannkind CorpPMCBLIBYvs. Q4 2022SEC
Q4 2022Feb 14, 202395$36.5MMannkind CorpPMCBSHFSvs. Q3 2022SEC
Q3 2022Nov 9, 2022118$57.0MSHFSMannkind CorpLMF Acquisition Opportunit Ivs. Q2 2022SEC
Q2 2022Aug 15, 2022120$61.6MSHF Holdings, Inc.Mannkind CorpLMF Acquisition Opportunit Ivs. Q1 2022SEC
Q1 2022May 12, 2022123$76.9MNeurocrine Biosciences IncMannkind CorpAtlas Air Worldwide Hldgs INvs. Q4 2021SEC
Q4 2021Feb 11, 2022118$106.1MAltair Engr IncBit Minin-SP ADRAtlas Air Worldwide Hldgs IN–SEC

13D and 13G filings

Companies where Ayrton Capital LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

27 companies, largest stake first.

Companies where Ayrton Capital LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
APVOAptevo Therapeutics Inc.13G10.00%358.1K sharesNewAug 13, 20251 filingAug 13, 2025SEC
ORGNOrigin Materials, Inc.13G9.99%17.0M sharesNewFeb 11, 20261 filingFeb 11, 2026SEC
AZTRAzitra, Inc.13G9.99%1.66M sharesNewMay 14, 20251 filingMay 14, 2025SEC
PWCMPowercompute, Inc.13G9.99%1.61M sharesNewNov 13, 20251 filingNov 13, 2025SEC
APUSApimeds Pharmaceuticals US, Inc.13G9.99%1.40M sharesNewFeb 11, 20261 filingFeb 11, 2026SEC
NVNINvni Group Ltd13G9.99%1.11M sharesNewFeb 11, 20261 filingFeb 11, 2026SEC
BTCTBTC Digital Ltd.13G9.99%1.01M sharesNewAug 13, 20261 filingAug 13, 2026SEC
CISSC3is Inc.13G9.99%856.2K sharesNewFeb 11, 20261 filingFeb 11, 2026SEC
GNLNGreenlane Holdings, Inc.13G9.99%849.8K sharesNewMay 14, 20251 filingMay 14, 2025SEC
PAVMPAVmed Inc.13G/A9.99%709.1K shares+0.09 ppfrom 9.90%Feb 14, 20243 filingsMay 11, 2026SEC
BNGOBionano Genomics, Inc.13G9.99%528.2K sharesNewNov 13, 20251 filingNov 13, 2025SEC
RENXRenX Enterprises Corp.13G9.99%278.5K sharesNewMay 11, 20261 filingMay 11, 2026SEC
AVXAvax One Technology Ltd.13G9.99%189.9K sharesNewMay 14, 20251 filingMay 14, 2025SEC
BJDXBluejay Diagnostics, Inc.13G9.99%107.7K sharesNewAug 13, 20261 filingAug 13, 2026SEC
Tritium DCFC LtdOrdinary Shares, no par value13G/A9.90%18.8M shares–Feb 14, 20242 filingsFeb 13, 2025SEC
OCEAOcean Biomedical, Inc.13G/A9.90%3.87M shares–Feb 14, 20242 filingsFeb 13, 2025SEC
FUVArcimoto Inc13G/A9.90%945.9K shares–Feb 14, 20242 filingsFeb 13, 2025SEC
PMCBPharmaCyte Biotech, Inc.13G/A9.90%774.1K shares–May 19, 20233 filingsFeb 13, 2025SEC
ATXGAddentax Group Corp.13G/A9.90%646.5K shares–Feb 14, 20242 filingsFeb 13, 2025SEC
SUNESUNation Energy, Inc.13G8.78%361.9K sharesNewAug 13, 20261 filingAug 13, 2026SEC
GWHESS Tech, Inc.13G/A8.14%2.56M shares−1.85 ppfrom 9.99%May 11, 20262 filingsAug 13, 2026SEC
FNGRFingerMotion, Inc.13G7.99%5.32M sharesNewAug 13, 20261 filingAug 13, 2026SEC
ICUSeaStar Medical Holding Corp13G6.52%278.4K shares+3.92 ppfrom 2.60%Nov 14, 20244 filingsMay 11, 2026SEC
PTPIPetros Pharmaceuticals, Inc.13G/A6.20%657.6K shares–Feb 14, 20243 filingsFeb 13, 2025SEC
MSAIMultiSensor AI Holdings, Inc.13G/A5.73%4.89M shares−4.26 ppfrom 9.99%Feb 11, 20262 filingsMay 11, 2026SEC

Showing the 25 largest of 27 stakes.

Latest filings

129 filings on file made by Ayrton Capital LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Ayrton Capital LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
GVHGlobavend Holdings LtdAug 13, 20261:00 PM ET13G/A0.00%59 shares−10.00 ppfrom 10.00%Below 5%Jun 30, 2026SEC
GOVXGeoVax Labs, Inc.Aug 13, 202612:56 PM ET13G/A1.59%118.7K shares−8.40 ppfrom 9.99%Below 5%Jun 30, 2026SEC
GWHESS Tech, Inc.Aug 13, 202612:53 PM ET13G/A8.14%2.56M shares−1.85 ppfrom 9.99%Jun 30, 2026SEC
MRLNMerlin, Inc.Aug 13, 202612:48 PM ET13G/A2.12%2.09M shares−5.27 ppfrom 7.39%Below 5%Jun 30, 2026SEC
FNGRFingerMotion, Inc.Aug 13, 202612:47 PM ET13G7.99%5.32M sharesNewJun 30, 2026SEC
ENVBEnveric Biosciences, Inc.Aug 13, 202612:40 PM ET13G/A2.93%111.1K shares−7.06 ppfrom 9.99%Below 5%Jun 30, 2026SEC
SUNESUNation Energy, Inc.Aug 13, 202612:39 PM ET13G8.78%361.9K sharesNewJun 30, 2026SEC
CHNRChina Natural Resources IncAug 13, 202612:34 PM ET13G/A5.26%69.7K shares+4.46 ppfrom 0.80%Jun 30, 2026SEC
BJDXBluejay Diagnostics, Inc.Aug 13, 202612:27 PM ET13G9.99%107.7K sharesNewJun 30, 2026SEC
DFSCDEFSEC Technologies Inc.Aug 13, 202612:23 PM ET13G/A2.95%102.9K shares−3.17 ppfrom 6.12%Below 5%Jun 30, 2026SEC
BTCTBTC Digital Ltd.Aug 13, 202612:17 PM ET13G9.99%1.01M sharesNewJun 30, 2026SEC
WWRWestwater Resources, Inc.May 11, 20266:15 PM ET13G/A3.71%4.80M shares−6.29 ppfrom 10.00%Below 5%Mar 31, 2026SEC
ASTIAscent Solar Technologies, Inc.May 11, 20266:07 PM ET13G/A0.03%2.82K shares−9.96 ppfrom 9.99%Below 5%Mar 31, 2026SEC
COCHEnvoy Medical, Inc.May 11, 20266:02 PM ET13G/A3.10%2.46M shares−4.77 ppfrom 7.87%Below 5%Mar 31, 2026SEC
RENXRenX Enterprises Corp.May 11, 20265:59 PM ET13G9.99%278.5K sharesNewMar 31, 2026SEC
GWHESS Tech, Inc.May 11, 20265:58 PM ET13G9.99%3.02M sharesNewMar 31, 2026SEC
PAVMPAVmed Inc.May 11, 20265:57 PM ET13G/A9.99%709.1K shares+0.09 ppfrom 9.90%Mar 31, 2026SEC
MSAIMultiSensor AI Holdings, Inc.May 11, 20265:55 PM ET13G/A5.73%4.89M shares−4.26 ppfrom 9.99%Mar 31, 2026SEC
ICUSeaStar Medical Holding CorpMay 11, 20265:52 PM ET13G6.52%278.4K shares+3.92 ppfrom 2.60%Mar 31, 2026SEC
GNPXGenprex, Inc.May 11, 20265:52 PM ET13G/A2.69%249.8K shares−7.03 ppfrom 9.72%Below 5%Mar 31, 2026SEC